Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2005

View Archived Issues

Combined statin and L-arginine treatment opens new possibilities for clinical research

XOS supplementation reported to improve the gastrointestinal microflora of obese patients

Sho-saiko-to selectively inhibits CD8+ cells

STELLAR 3 trial of Xyotax reaches required number of events

Orphan drug designation for Tocosol Paclitaxel for bladder cancer indication

Agreements to develop AP-23573 drug delivery stents

Tarvacin cleared to enter new phase I study

NIDA grant supports drug addiction therapy development at InfleXion

Orphan drug status for PTC-124 for Duchenne muscular dystrophy

Quadramet and docetaxel to be evaluated for cancer spread to bone

GSK and Transport sign agreement for iontophoretic delivery of aciclovir

Thiazolidinediones show promise in the treatment of diabetic vascular complications

Fast track status for Viprinex for ischemic stroke

Analgesic effects reported for AM-404 in a model of neuropathic pain

Enrollment completed in study of Durin-leuprolide implant for Alzheimer's

Provensis seeks to lift Varisolve clinical hold

Neuroprotective effects of ethyl pyruvate in a preclinical model of Parkinson's disease

Chiesi and Novartis sign agreement for Formoterol Modulite

Tanabe Seiyaku signs addendum to Remicade license agreement in Japan

Rigel claims agents for hepatitis C infection

Kowa scientists describe new compounds for diabetes and related complications

New MCHR antagonists for obesity and other uses reported by Banyu

Two series of cannabinoid receptor modulators disclosed by Japan Tobacco

Pharmacia identifies new protein kinase inhibitors

New DPP-IV inhibitors discovered at Syrrx

5HT-7 receptor modulators and their use in IBS claimed by Ajinomoto

Amgen launches Kepivance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...